Cardioverter Defibrillator Devices Market is Expected to reach at 12,520 Million USD By 2022
The global cardioverter defibrillator devices market is driven by increasing incidence & prevalence
of cardiovascular diseases in older as well as younger population; increasing
sedentary lifestyle and obesity rate along with excessive consumption of
tobacco, alcohol, and caffeinated products; rising aging population; and various
technological advancements. However, lack of skilled professionals; and
increasing incidence of defibrillator malfunction and product recalls offer a
great challenge for the growth of cardioverter defibrillator devices market.
The global cardioverter
defibrillator devices market will grow at a CAGR of 4.6% from 2017 to 2022 to
reach USD 12,520 million by 2022, according to the latest publication by
Meticulous Research.
The global cardioverter
defibrillator devices market is mainly segmented by product, end-user, and
geography. On the basis of product, this market is segmented into implantable
cardioverter defibrillator and external cardioverter defibrillator.
To Request Sample Report @ https://www.meticulousresearch.com/request-sample-report/?cp_id=3596
The Report include Following Things-
·
Introduction
·
Research
Methodology
·
Executive
Summary
·
Market
Insights
·
Cardioverter Defibrillator Devices Market, By
Product
·
Cardioverter
Defibrillator Devices Market, By End-User
·
Cardioverter
Defibrillator Devices Market, By Geography
·
Competitive
Landscape
· Company
Profiles (Business Overview, Recent Financials, Product Portfolio, and Recent
Strategic Developments)
· Appendix
The cardioverter defibrillator
devices market is highly competitive and consolidated with the top three-four
players holding the major share of the market. Medtronic PLC, Abbott
Laboratories, and Boston Scientific Corporation are the key players in implantable
cardioverter defibrillators market, whereas; Koninklijke Philips N.V., Cardiac
Science Corporation, and Zoll Medical Corporation are leading the external
defibrillators market.
The key players in the global
cardioverter defibrillator devices market are Medtronic plc (Ireland), Abbott
Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE &
Co. KG (Germany), and LivaNova PLC (U.K.), Stryker Corporation (U.S.),
Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti
srl (Italy), Fukuda Denshi Co. (Japan), Schiller AG (Switzerland), Cardiac
Science corporation (U.S.), and Zoll medical corporation (U.S.).
Contact Us:
Viren Shrivastava
AVP- Global Sales and Marketing
Email: viren@meticulousresearch.com
Comments
Post a Comment